Free Trial

HUTCHMED (HCM) News Today

HUTCHMED logo
$14.60 -0.25 (-1.68%)
Closing price 04:00 PM Eastern
Extended Trading
$14.76 +0.17 (+1.13%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HCM Latest News

HUTCHMED (China) Limited stock logo
18,102 Shares in HUTCHMED (China) Limited (NASDAQ:HCM) Acquired by Marshall Wace LLP
Marshall Wace LLP acquired a new stake in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 18,102 shares of the company's stock, valued at approximately $261,000. Other institutional investors
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Trading 3.9% Higher - Here's Why
HUTCHMED (NASDAQ:HCM) Shares Up 3.9% - Should You Buy?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Down 5.7% - Should You Sell?
HUTCHMED (NASDAQ:HCM) Trading Down 5.7% - Time to Sell?
HUTCHMED (China) Limited stock logo
Renaissance Technologies LLC Has $2.72 Million Holdings in HUTCHMED (China) Limited (NASDAQ:HCM)
Renaissance Technologies LLC lifted its position in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 18.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 188,539 shares of the company's stock a
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy?
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Down - What's Next?
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Trading Up 6.9% - Time to Buy?
HUTCHMED (NASDAQ:HCM) Trading Up 6.9% - Should You Buy?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Up - What's Next?
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Still a Buy?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Up 8.3% - Here's Why
HUTCHMED (NASDAQ:HCM) Shares Up 8.3% - Here's What Happened
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Should You Sell?
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's Why
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Trading Up 7.5% - Here's Why
HUTCHMED (NASDAQ:HCM) Shares Up 7.5% - What's Next?
HUTCHMED (China) Limited stock logo
HUTCHMED (China) Limited (NASDAQ:HCM) Shares Sold by Schroder Investment Management Group
Schroder Investment Management Group lowered its stake in shares of HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,768,941 shares of the
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's Why
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's What Happened
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Time to Sell?
HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's What Happened
HUTCHMED (China) Limited stock logo
HUTCHMED (China) Limited (NASDAQ:HCM) Shares Sold by Connor Clark & Lunn Investment Management Ltd.
Connor Clark & Lunn Investment Management Ltd. reduced its stake in HUTCHMED (China) Limited (NASDAQ:HCM - Free Report) by 38.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,109 shares of the company's
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of HUTCHMED from a "hold" rating to a "buy" rating in a research note on Friday.
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% - Time to Sell?
HUTCHMED (NASDAQ:HCM) Stock Price Down 5.7% - Should You Sell?
Hutchmed says NDA for Tazverik granted conditional approval in China
Hutchmed reports FY24 EPS 22c vs. 59c last year
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
HUTCHMED Reports 2024 Full Year Results and Provides Business Updates
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Share Price Crosses Above Fifty Day Moving Average - Time to Sell?
HUTCHMED (NASDAQ:HCM) Stock Price Crosses Above 50 Day Moving Average - Here's Why
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Stock Price Up 6.3% - Here's Why
HUTCHMED (NASDAQ:HCM) Stock Price Up 6.3% - What's Next?
HUTCHMED (China) Limited stock logo
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Should You Buy?
HUTCHMED (NASDAQ:HCM) Shares Gap Up - Here's Why
HUTCHMED to Announce 2024 Final Results
Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

HCM Media Mentions By Week

HCM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HCM
News Sentiment

1.11

0.64

Average
Medical
News Sentiment

HCM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HCM Articles
This Week

1

3

HCM Articles
Average Week

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:HCM) was last updated on 5/7/2025 by MarketBeat.com Staff
From Our Partners